ClinicalTrials.gg
Not yet recruitingNCT07759570PIP-PAINUpdated Aug 12, 2026

Parasternal Intercostal Plane Catheter for Pain Control After CABG Surgery

An interventional study of Parasternal blocks in Bypass Surgery, Arrythmia and Postoperative Pain, sponsored by Koc University Hospital. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-12.

Sponsored by Koc University Hospital · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 23 studies in Arrhythmias, Cardiac with a site in Turkey — 3 open to participants now, 5 under way, none of them phase 3. Arrhythmias, Cardiac · Turkey.

Planned enrollment
8th of 12
56 · median 63
Started
2026
with 1 other
No phase
10 of 23
3 open now
Registered
21st of 23
by date

Among the 23 studies in Arrhythmias, Cardiac with a site in Turkey, this one is the 8th largest by planned enrollment of the 12 interventional ones that give a count, is one of 2 that started in 2026, is one of 10 with no phase, and was the 21st registered.

Arrhythmias, Cardiac

1,052 studies on the registry are indexed under Arrhythmias, Cardiac; 236 are open to participants now.

Browse Arrhythmias, Cardiac studies →

Open to participants now

3 of the 23 studies in Arrhythmias, Cardiac with a site in Turkey are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 167 Arrhythmias, Cardiac studies recruiting now, 119 (71%) set no upper age limit and 13 (8%) stop at 75 or younger; 31 take children under 18; 26 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies in Arrhythmias, Cardiac with a site in Turkey, or all of them as a file.
02

Study summary

Coronary artery bypass graft (CABG) surgery performed via sternotomy (incision of the breastbone) can cause severe pain after surgery; this can slow recovery and increase the need for opioid pain relievers. This study investigates whether placing a catheter to deliver a local anesthetic to the superficial parasternal intercostal plane reduces pain following this type of heart surgery. Patients undergoing CABG via sternotomy will be randomly assigned to either the catheter-based analgesia group or the standard pain management group. The researchers will compare postoperative pain levels and analgesic medication requirements between the two groups to determine whether this technique improves postoperative pain control.

Read the detailed description

Patients undergoing coronary artery bypass surgery will be included. Patients will be divided into two groups: the block group, in which a bilateral superficial parasternal plexus catheter will be inserted, and the control group, in which no parasternal plexus block or catheter will be administered.

In the block group, the catheter placement will be performed after completion of the surgery and before the patient is transferred to the ICU, under ultrasound guidance (Venue Go, GE, L4-T12 high-frequency linear probe). The probe will be positioned transversely across the costal cartilage, parallel to the sternum, in a parasagittal orientation at the level of 3rd rib. A 5-cm Tuohy needle will be inserted 2 cm lateral to the midline and advanced between the pectoralis major and external intercostal muscles at the third parasternal intercostal space. Needle tip position will be confirmed by negative aspiration for blood or air, followed by injection of 20 mL of bupivacaine 0.2% into the parasternal plane. Correct needle position will be confirmed by visualization of local anesthetic spread and hydrodissection separating the pectoralis major from the ribs and external intercostal muscles. A catheter (Tuohy Ultra-360 18G, B. Braun Contiplex, 400 mm) will then be placed into the parasternal intercostal space. Catheter position will be confirmed by ultrasound visualization of spread of 10 mL saline, after which the catheter will be secured. The procedure will be performed bilaterally. Postoperatively, 20 mL of bupivacaine 0.2% will be administered by the clinician through each parasternal catheter at 12, 24, 36, 48, 60, and 72 hours. Catheters will be removed by the clinician at 72 hours. Catheter-related complications, including bleeding, infection, and dislocation, will be recorded.

In the control group, no parasternal plexus block or catheter will be placed.

Intraoperative anesthesia technique will be identical in both groups. All patients will be admitted to the ICU orotracheally intubated and will be extubated in the ICU rather than in the operating room.

Pain nurses will assess all patients every 12 hours for 72 hours postoperatively. At each visit, pain score will be recorded using the Visual Analog Scale, where 0 corresponds to no pain and 10 corresponds to worst pain, assessed both at rest and during movement. Postoperative opioid consumption will be monitored via a patient-controlled analgesia device. The Morphine PCA solution will be prepared at a concentration of 1 mg/mL, with no background infusion, a bolus dose of 1 mL, and a lockout interval of 15 minutes. Additional (rescue) opioid analgesic requirements will be recorded by pain monitoring nurses. Rescue analgesia in both groups will consist of tramadol 1 mg/kg administered intravenously.

Patients' heart rhythm will be monitored continuously via telemetry throughout their hospital stay. Atrial tachyarrhythmias, including atrial flutter and atrial fibrillation, will be recorded throughout the hospital stay. Nausea, vomiting, and constipation will be recorded for 72 hours postoperatively.

Patient satisfaction will be assessed using a 5-point Likert scale, where 1 corresponds to strongly not satisfied and 5 corresponds to strongly satisfied. Hospital length of stay, ICU length of stay, and time to extubation in the ICU will be recorded for both groups.

03

Conditions studied

  • Bypass Surgery
  • Arrythmia
  • Postoperative Pain

Keywords

  • parasternal block
  • postoperative analgesia
  • cardiovascular surgery
  • arrhythmia
  • regional anesthesia
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- Adult patients with coronary artery disease scheduled for coronary artery bypass graft surgery

Exclusion criteria

Exclusion Criteria:

  • Under 18 years of age
  • ASA () Class V patients
  • Non-elective emergency cases
  • Patient refusal to participate in the study
  • Language barrier
  • Patients who have previously undergone sternotomy
  • History of significant psychiatric disorders
  • Patients with known long-term opioid use
  • Patients with potential to nerve blocks (bleeding diathesis, infection, and allergy to local anesthetics)
  • Patients with an \<40%
  • Patients with right ventricular systolic dysfunction (patients with TAPSE \<1.8 cm)
  • Patients with a left atrial diameter >4 cm
  • Patients with severe valvular heart disease
  • Patients undergoing concomitant valvular heart surgery
  • Patients with a history of atrial flutter and/or atrial fibrillation
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
56 participants (estimated)

Study arms

  • Active comparator
    Block group

    Patiens receiving bilateral superficial parasternal catheter at the end of the surgery

    Other: Parasternal blocks

  • No intervention
    Control group

    No superficial parasternal catheter will be placed

Interventions

  • OtherParasternal blocks

    Bilateral superficial parasternal block catheters will be placed at the end of the surgery, at the level of 3rd rib using ultrasound guidance

06

What researchers measure

Primary outcomes

  1. Cumulative opioid consumption at 24 hours post-operatively (mg morphine equivalent).

    Cumulative opioid consumption (patient controlled analgesia and rescue analgesia) at the first 24 hours postoperatively

    Time frame: Postoperative 24 hours

Secondary outcomes

  1. Resting NRS pain scores at 12, 24, 36, 48, 60, and 72 hours post-Surgery

    Resting pain levels of patients will be evaluated using the numeric rating scale where 0 point meaning no pain and 10 points meaning the worst pain possible

    Time frame: at 12, 24, 36, 48, 60, and 72 hours post-Surgery

  2. NRS pain scores associated with coughing at 12, 24, 36, 48, 60, and 72 hours post-Surgery

    Pain levels associated with cough of patients will be evaluated using the numeric rating scale where 0 point meaning no pain and 10 points meaning the worst pain possible

    Time frame: at 12, 24, 36, 48, 60, and 72 hours post-Surgery

  3. Total amount of opioids consumed during the first 72 hours after surgery

    Time frame: at the first 72 hours after surgery

  4. Time to first rescue analgesic administration

    The time when rescue analgesia is first administered during the postoperative recovery period

    Time frame: The patient will be monitored for the first 72 hours after surgery.

  5. Time to extubation (in minutes) following admission to the postoperative intensive care unit

    It will be recorded as postoperative minutes.

    Time frame: From intensive care unit admission until extubation, assessed up to 72 hours after intensive care unit admission

  6. Length of stay in the intensive care unit

    Time frame: From intensive care unit admission until ICU discharge, assessed up to 14 days after intensive care unit admission

  7. Length of hospital stay

    Time frame: From surgery until hospital discharge, assessed up to 30 days after intensive care unit admission

  8. Assessment of Patient Satisfaction Using a numeric rating scale

    Patients will be asked "How satisfied are you with your pain treatment" at 72 hours after surgery. A numeric rating scale will be used where 0 point meaning not satisfied at all and 10 points meaning can not be satisfied more.

    Time frame: at the 72nd hour postoperatively

  9. Bleeding associated with a peripheral block catheter

    Time frame: for 72 hours after surgery

  10. Postoperative Nausea and Vomiting

    Time frame: for 72 hours after surgery

  11. Time to first bowel movement

    Postoperative time to first bowel movement (defecation or flattus)

    Time frame: for 72 hours after surgery

  12. Postoperative arrhythmia

    Patients will be monitored via telemetry during their discharge period.

    Time frame: During the first 72 hours after surgery

  13. Postoperative catheter-site infection

    Time frame: From the end of the surgery until hospital discharge, assessed up to 30 days after surgery

  14. Dislocation of the parasternal block catheter

    After the catheter is placed using ultrasound, the catheter site will be verified with saline.

    Time frame: During the first 72 hours after surgery

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — Anonymized patient data will be published in a public repository

Time frame: Starting at the completion of the study (anticipated November 2026) with no end date

Access criteria: Anonymized patient data will be open to be accessed by any researcher

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2026; primary completion for Oct 2026, 2 months later.

Of 172 non-industry interventional studies with no phase under Arrhythmias, Cardiac, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 43. This study's planned 2 months is below that.

Counting every sponsor, half of 243 studies reached it within 24 months; a quarter within 12 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 31, 2026
First posted
Aug 12, 2026
StartEst.
Aug 30, 2026
Primary completionEst.
Oct 30, 2026
CompletionEst.
Nov 15, 2026
Last update
Aug 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07759570
Lead sponsor
Koc University Hospital
Responsible party
Rafet Onur Gorgulu (MD, Resident, Koc University Hospital) — Principal investigator
First posted
Aug 12, 2026
Start date
Aug 30, 2026 (estimated)
Primary completion
Oct 30, 2026 (estimated)
Completion
Nov 15, 2026 (estimated)
Last update
Aug 12, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion